T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
T2 Biosystems Inc TTOO
News
-
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
T2 Biosystems Gets 510(k) Clearance For Expanded T2Bacteria Panel
T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024
U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize
T2 Biosystems reaches regulatory milestone that could be a game changer, analyst says
T2 Biosystems' stock extends losing streak despite FDA approval for anthrax and plague diagnostic test
T2 Biosystems touts 'highly differentiated' products in fight against sepsis
T2 Biosystems stock falls 16.1% premarket after snapping 3-day winning streak
T2 Biosystems stock climbs more than 4% premarket to continue rally
T2 Biosystems stock surges more than 14% premarket to continue rally
T2 Biosystems's stock falls 8.7% premarket after generating meme-like buzz